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Key questions
What is already known?
 Ź User charges are widely used as a health inancing 
mechanism in many low-income and middle-in-
come countries, but the relationships between user 
charges and health outcomes have not been exam-
ined in a systematic review.
What are the new indings?
 Ź Improved access to healthcare due to a lower level 
of out-of-pocket expenditure from user charges was 
identiied as a potential explanatory factor for im-
proved health outcomes.
 Ź This systematic review found that reducing user 
charges was associated with improvements in 
health outcomes, especially among children and 
lower-income populations.
What do the new indings imply?
 Ź These indings highlight the importance of shifting 
away from user charges to inance universal health 
coverage towards use of prepayment through taxa-
tion and insurance contributions.
 Ź Reducing user charges for vulnerable populations 
can reduce inancial hardship from healthcare pay-
ments, which in turn improves health outcomes and 
promotes health equity.
AbsTrACT
background User charges are widely used health inancing 
mechanisms in many health systems in low-income and 
middle-income countries (LMICs) due to insuficient public 
health spending on health. This study systematically reviews 
the evidence on the relationship between user charges 
and health outcomes in LMICs, and explores underlying 
mechanisms of this relationship.
Methods Published studies were identiied via electronic 
medical, public health, health services and economics 
databases from 1990 to September 2017. We included 
studies that evaluated the impact of user charges on 
health in LMICs using randomised control trial (RCT) or 
quasi-experimental (QE) study designs. Study quality was 
assessed using Cochrane Risk of Bias and Risk of Bias in 
Non-Randomized Studies—of Intervention for RCT and QE 
studies, respectively.
results We identiied 17 studies from 12 countries 
(ive upper-middle income countries, ive lower-middle 
income countries and two low-income countries) that met 
our selection criteria. The indings suggested a modest 
relationship between reduction in user charges and 
improvements in health outcomes, but this depended on 
health outcomes measured, the populations studied, study 
quality and policy settings. The relationship between reduced 
user charges and improved health outcomes was more 
evident in studies focusing on children and lower-income 
populations. Studies examining infectious disease–related 
outcomes, chronic disease management and nutritional 
outcomes were too few to draw meaningful conclusions. 
Improved access to healthcare as a result of reduction in out-
of-pocket expenditure was identiied as the possible causal 
pathway for improved health.
Conclusions Reduced user charges were associated with 
improved health outcomes, particularly for lower-income 
groups and children in LMICs. Accelerating progress towards 
universal health coverage through prepayment mechanisms 
such as taxation and insurance can lead to improved health 
outcomes and reduced health inequalities in LMICs.
Trial registration number CRD 42017054737.
InTroduCTIon
Achieving universal health coverage (UHC)—
defined as ensuring timely access to quality 
healthcare without financial hardship1—is a 
target for the Subtainable Development Goal 
3 (SDG 3). UHC has also been identified as an 
important instrument for countries to attain 
other key SDGs, including poverty reduction 
(SDG 1), reduced gender inequality (SDG 
5), inclusive economic growth (SDG 8) and 
reduced inequalities (SDG 10).2 3
Alternative approaches to finance UHC 
and their associated impacts on the SDGs is 
an emerging area of research. Among the 
four financing strategies to achieve UHC 
recommended by WHO (ie, increasing effi-
ciency of taxation, reprioritising government 
budgets towards health, innovative financing, 
increasing development assistance for 
health), risk pooling with prepayment is one 
of the most promising strategies.4 5 However, 
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in low-income and middle-income countries (LMICs), 
user charges, which are fees incurred at the point of 
care, are widely used as a health financing mechanism 
to modulate demand for healthcare and to supplement 
shortfalls in public spending on health.6 7 Recent statis-
tics have shown that out-of-pocket spending (including 
user charges) accounts for a large proportion of total 
health expenditure in many of the most populous LMICs, 
including Brazil (higher than 28%), China (higher than 
32%), Ethiopia (higher than 38%), India (higher than 
65%), Indonesia (higher than 48%), Nigeria (72%) and 
Pakistan (higher than 66%).8 9 Out-of-pocket spending 
can have an impoverishing impact, especially among 
low-income groups.4 10
There is growing attention to the relationship between 
user charges and population health outcomes in LMICs. 
Evidence from high-income countries (HICs) shows that 
reducing user charges can improve population health 
outcomes due to more timely treatment and enhanced 
adherence to medication.11–13 However, there may be 
dangers in extrapolating findings from HICs to LMICs 
where health systems are more fragmented and the cost 
of healthcare may be a greater barrier for patients to 
access services.8 14
The relationship between user charges and access to 
healthcare has been well documented; however, less 
is known about the impact of user charges on health 
outcomes in LMICs. The aim of this study is to review and 
synthesise evidence from robust empirical studies, such 
as randomised control trials (RCTs) and quasi-experi-
mental (QE) studies, on the impact of user charges on 
health outcomes in LMICs and explore potential explan-
atory mechanisms for the associations identified.
MeTHods
We followed the methods detailed in a peer-reviewed 
systematic review protocol that is registered with PROS-
PERO (registration CRD 42017054737).
search strategy
In September 2017, we conducted searches of electronic 
medical and economics databases (MEDLINE, Econlit, 
Scopus, JSTOR, WHO Library Database, World Bank 
e-Library) to locate studies about the impact of user 
charges on health outcomes in LMICs. We included all 
types of health outcomes with quantitative measures, with 
the search strategy based on a combination of three sets 
of keywords—(1) health, (2) synonyms of user charges 
and (3) a list of LMICs (detailed search strategy can be 
found in online appendix—database search strategy):
 Ź Synonyms of health.
 Ź User charges: “reimbursement”, “copayment”, “cost 
sharing”, “coinsurance”, “deductible”, “user charge”, 
“user fee”, “out-of-pocket”, “health insurance”, 
“medical insurance”.
 Ź LMICs: “Low and middle income country”, “Asia”, 
“South East Asia”, “Central Asia”, “sub-Saharan”, 
“Africa”, “South America”, “Latin”, “low-income 
country”, “middle-income country”, “developing 
country”, “under developed” and all LMICs listed in 
the World Bank website in year of 2016.15
The searches were restricted to studies written in 
English (peer-reviewed articles, working papers, confer-
ence papers and reports) published from January 1990 
to September 2017. We also carried out additional litera-
ture searches by appraising reference lists of the studies 
identified.
Inclusion and exclusion criteria
User charges were defined as direct payments made at 
the time of health service use,16 with any possible combi-
nation of fees from registration, consultation, drugs and 
medical supplies, treatment, hospitalisation, delivery 
fees, laboratory tests or other health services provided in 
public or publicly subsidised sectors. The charges could 
be paid based on each visit to a healthcare provider or for 
treatment of the whole episode of illness.7
Studies were screened based on the inclusion and 
exclusion criteria shown in table 1. All study popula-
tions were eligible. For outcomes, we considered both 
self-reported and clinically measured health outcomes in 
relation to both increases and decreases in user charges. 
As eligible interventions, only studies which examined 
changes in the levels of user charges (in either direction 
or magnitude) were included, while studies focusing on 
the impact of health insurance without explicitly exam-
ining changes in user charges were excluded.
To synthesise findings from robust evidence, we only 
included studies with either QE or RCT study designs 
to control for confounding and bias. For example, esti-
mated policy effects could be biassed if self-selection 
exists, when individuals who expect to have high health-
care use choose insurance schemes with lower user 
charges.7 Therefore, the relationship between the levels 
of user charges, healthcare use and health outcomes may 
have elements of reverse causality.17 A broad definition of 
QE was considered which included difference-in-differ-
ences (DID), propensity score matching (PSM), instru-
mental variable (IV), regression discontinuity (RD) and 
interrupted time series (ITS).18–20 To isolate changes in 
health outcomes attributing to user charges, we removed 
studies that evaluated multifaceted policy changes (from 
both demand or supply sides) or consisted of several 
concurrent policy changes which precluded assessment 
of individual policy impacts.
One reviewer (VMQ) independently reviewed titles 
and abstracts and discussed with another reviewer (JTL) 
on the uncertain studies. Subsequently, full texts were 
screened for eligibility by two independent reviewers 
(VMQ and JTL). Any disagreements were resolved 
through discussion with a third reviewer (TH).
Quality assessment
Quality assessments were dependent on risk of bias for 
each study. We used a modified ROBINS-I (Risk of Bias 
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Table 1 Inclusion and exclusion criteria for study selection based on PICOS
Selection 
criteria Inclusion criteria Exclusion criteria
Population LMICs Non-LMICs
Intervention Isolated demand-side user charge changes attributed 
to inancing policy or health insurance scheme for 
health services, including increased, decreased, 
introduction and abolition of user charges. The study 
could either mention direction or magnitude changes in 
amount or proportion of user charges
Examined complex intervention: both of demand-
side and supply-side intervention
Examined concurrent policy changes
Only examined the impact of health insurance 
without explicitly mentioning changes in user 
charges
Comparator Individuals or communities in LMICs that were not 
exposed to user charge changes during the period of 
study
None
Outcome All types of health outcomes (eg, general health status, 
mortality, non-communicable disease, infectious 
disease, nutritional and anthropometric measurements)
Only assessed health service use
Study design Quasi-experimental study design: difference-in-
differences, propensity score matching, instrumental 
variable, regression discontinuity, interrupted time 
series and any combination of these designs
Randomised control trial, cluster-randomised control 
trial
Cross-sectional study, simple before–after 
comparison, qualitative study, cost–beneit/cost-
effectiveness analysis, systematic review, meta-
analysis, commentary
LMIC, low-income to middle-income country.
in Non-Randomised Studies—of Interventions) tool21 
for studies adopting a QE design. First, we assessed 
the risk of biases (two relating to pre-intervention, one 
relating to at-intervention, four relating to post-inter-
vention) for each QE to reach an overall risk of bias (ie, 
low/moderate/serious/critical/no information). We 
graded the quality of each QE as high (low risk of bias), 
moderate (moderate risk of bias) or low (serious risk of 
bias or below) based on the overall risk of bias.
We used the Cochrane Risk of Bias tool to assess seven 
domains of biases for studies adopting an RCT design. 
The quality of the RCT was then graded high (low risk of 
bias for more than five domains), moderate (high risk of 
bias for two domains) or low (high or unclear risk of bias 
for more than two domains).22
data extraction and synthesis
The data extracted from selected articles consisted of the 
study setting, detail on the change in user charge policy, 
study design, data sources, follow-up period and key find-
ings on health outcomes. We also examined secondary 
outcomes, such as access to healthcare and levels of 
financial protection, where possible.
Due to heterogeneity in policy settings, countries, study 
designs, intervention and outcomes, meta-analysis was not 
feasible. We conducted a narrative review and reported 
effects, stratified by different types of health outcomes. 
We also outlined effects for secondary outcomes to 
explore possible mechanisms of action between user 
charges and health outcomes. We analysed the impact of 
user charges policies on health by different population 
groups, such as low-income populations and children, to 
explore whether impact varied by population groups.
Additionally, we undertook an analysis to understand 
the evidence gap by graphically displaying the knowledge 
gap of the findings in type of health outcomes and popu-
lation studied, and quality of the studies.
resulTs
study characteristics
We identified 6902 citations from bibliographic databases 
and an additional 73 from other sources. After removal 
of duplicates, 5683 unique citations were screening by 
title and abstract, and 336 full texts were sourced. Of 
these studies, 319 studies were excluded for the following 
reasons: a policy resulting in user charge change not 
evaluated (56 studies); health outcomes not studied (100 
studies); QE or RCT study designs not employed (123 
studies); not based in LMICs (26 studies); and other 
reasons such as duplicate studies, unrelated topics, under 
review or no full text available (14 studies). Seventeen 
studies met the final inclusion criteria. Figure 1 provides 
details of the process of study identification.
The 17 included studies were conducted in 12 LMICs: 
five upper-income to middle-income countries—China 
(two studies), Georgia (one study), Jamaica (one study), 
South Africa (one study) and Mexico (two studies); five 
LMICs—India (three studies), Vietnam (three studies), 
the Philippines (one study), Ghana (one study) and 
Kenya (one study); and two low-income countries—
Senegal (one study) and Nepal (one study). Of the 17 
studies, 14 were published after 2010. One study was an 
RCT, nine used DID design, two employed RD, three 
used PSM, one used DID design with PSM (DID-PSM) 
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Figure 1 Synthesis of study identiication in review of 
the effects of user charges on health in low-income and 
middle-income countries (LMICs). *Other sources include 
WHO Library Database, World Bank e-Library and manually 
searched references of the included papers. QE, quasi-
experimental; RCT, randomised controlled trial.
and one used IV regression. More details of study charac-
teristics are shown in table 2.
A range of health outcomes were studied and catego-
rised into five groups (figure 2): general health outcomes 
(nine studies), mortality (four studies), infectious 
disease–related outcomes (three studies), chronic condi-
tion–related outcomes (three studies), and nutritional 
and anthropometric outcomes (two studies).
Changes in user charge policies were classified as 
removing user charges (15 studies), reducing user charges 
(one study) or increasing user charges (one study). 
Thirteen studies examined user charges in primary or 
outpatient services, while four examined user charges 
in secondary and tertiary care. The majority (14/17) of 
the studies examined relevant secondary outcomes on 
access to healthcare and levels of financial protection. 
The median follow-up period from intervention to the 
last observation was 45 months, with a range of 12–144 
months. Studies on chronic condition–related outcomes 
had the longest median follow-up period of 72 months.
Quality of included studies
Overall study quality was moderate, with four studies of 
high quality, 10 of moderate quality and three of low 
quality. Areas of potential bias that many QEs failed to 
address were potential selection bias (six studies) with the 
possibility selection could be related to intervention status 
or outcome, and potential recall or misclassification bias 
(seven studies) as using self-reported health outcomes 
may have affected the ‘measurement of outcomes’. The 
quality of the only RCT study included was rated high 
with nearly all domains assessed at low risk except the 
domain ‘performance bias’, which was high risk as partic-
ipants were un-blinded to the intervention which may 
contaminate the results (online supplementary table 1).
Findings on the relationships between user charges and 
health outcomes
General health outcomes
Nine studies23–31 evaluated the impact of user charges 
on general health (three in Vietnam, two in China, two 
in India, one in Jamaica, one in Georgia) (table 3). In 
terms of outcomes measured, three studies measured 
changes in the number of sick days30 32 33 and six in self-re-
ported health status31 34–38 (online supplementary table 
2). Eight studies examined the impact of reducing user 
charges and one focused on the impact of increasing 
user charges. Five out of eight studies (based in Vietnam, 
India and Jamaica23 24 26 29 30) showed that reducing user 
charges was associated with fewer sick days and improved 
self-reported well-being. Nguyen and Wang,26 a high-
quality study, evaluated the Free Care for Children under 
Six policy in Vietnam, where they found removing user 
fees from inpatient and outpatient services for non-poor 
children under 6 years old associated with a 26% reduc-
tion in self-reported number of sick days, along with a 
significant increase in the use of secondary care, and 
a substitutional reduction in the use of tertiary care. 
Sood and Wagner, a moderate-quality study, evaluated 
the impact of the Indian Vajpayee Arogyashree Scheme 
(VAS) programme which provided free tertiary care for 
the poor in the state of Karnataka,24 where they found 
that removing user charges was associated with a signif-
icant improvement on post-hospitalisation well-being, 
accompanied by 4.4% more frequent treatment seeking 
by VAS participants and 16.5% reduction in re-hospitali-
sation subsequently.
Mortality
Four studies assessed the impact of reducing user charges 
on mortality (two on neonatal mortality, one on mortality 
for children under 5 and one on mortality for the total 
population) in India, Ghana, Nepal and multi-African 
countries32 39–41 (online supplementary table 3). Most 
studies included (three out of four studies) found that 
removing or reducing user charges was associated with 
reduced mortality. User charge reduction in these three 
studies applied to tertiary care and maternal care. For 
instance, McKinnon et al,41 a moderate-quality study, 
conducted a multicountry analysis in Africa to assess 
removing user fees from facility-based delivery for 
women, where they found a 9% reduction in neonatal 
death as well as a 5% increase in facility-based delivery in 
the policy countries (Ghana, Kenya, Senegal) compared 
with the control countries (Cameroon, Congo, Ethiopia, 
Gabon, Mozambique, Nigeria and Tanzania).
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Table 2 Summary characteristics of included studies (N=17)
Characteristic Asia America Africa Europe Total
Study published year
  1990–2000 0 0 0 0 0
  2001–2010 1 1 1 0 3
  2011–2017 10 2 2 1 14
Study design
  DID 6 1 2 0 9
  RD 2 0 0 1 3
  PSM 1 1 0 0 2
  IV 0 1 0 0 1
  PSM-DID 1 0 0 0 1
  RCT 1 0 0 0 1
Changes in user charges
  Increasing 1 0 0 0 1
  Decreasing 1 0 0 0 1
  Introducing 0 0 0 0 0
  Abolishing 8 3 3 1 15
Economy*†
  Upper middle income 2 3 1 1 7
  Lower middle income 7 0 2 0 10
  Low income 1 0 1 0 2
Health outcomes‡
  General health 7 0 1 1 9
  Mortality 2 0 2 0 4
  Infectious disease–related outcomes 2 0 1 0 3
  Chronic condition–related outcomes 0 2 0 0 3
  Nutritional outcomes 0 0 1 0 2
Age group of the study population
  General 5 2 0 1 8
  Women 1 0 2 0 3
  Children 3 0 2 0 5
  Elderly 0 1 0 0 1
Social economic status of the study population§
  Poor 5 2 0 1 8
  General 5 1 3 0 9
*According to World Bank country classiication 2016.
†The multicountry analysis consisted of three countries: two middle-income and one low-income countries.
‡The sum of health outcome category may be double entered because some studies evaluated more than one type of health 
outcome. America in this review included both South and Latin America.
§As deined in the context of the study.
DID, difference-in-difference; IV, instrumental variable; PSM, propensity score matching; RCT, randomised controlled trial; 
RD, regression discontinuity.
Infectious disease–related outcomes
Three studies assessed the impact of removing user charges 
on infectious disease–related outcomes (one in Ghana, 
India and the Philippines, respectively)24 33 39 (online 
supplementary table 4). Outcomes measured included 
postoperative infections, malaria-caused parasitaemia 
and pneumonia, and diarrhoea-related C reactive 
protein, with mixed results. Improvement in infectious 
disease–related outcomes was found in two studies 
assessing the removal of user charges on tertiary care in 
India and Philippines, while no improvement was found 
in the study on the removal of user charges for primary 
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Figure 2 Intervention focus and outcome studies.
care and secondary care in Ghana. Ansah et al, a RCT 
study, assessed the impact of free primary care, drugs and 
initial secondary care for children under 5 years old on 
various health outcomes in Ghana.39 Although this study 
found that removing user charges had an impact on 
healthcare use, no significant health benefits were found 
in the health outcomes assessed, including anaemia, 
anthropometric measurement, child mortality and para-
site prevalence.
Chronic condition–related outcomes
Three studies evaluated the impact of reducing user 
charge on chronic condition–related outcomes (with 
two studies in Mexico and one in Ghana)39 42 43 (online 
supplementary table 5). Outcomes in these three studies 
included blood glucose control (HbA1c), adherence 
to medication, diet and exercise for hypertension and 
diabetes, and anaemia. All three studies found reducing 
user charges was associated with improved chronic 
condition–related outcomes. Sosa-Rubi et al, a moder-
ate-quality study, compared enrolees in the Seguro 
Popular (SP) programme in Mexico, for whom the 
programme removed copayment for health services for 
diabetes, with those non-participants where no such 
benefit was introduced. They found that the SP enrolees 
had 9.5% greater access to blood glucose control test, 3.1 
times more insulin injections and more physician visits 
than those non-participants, with 5.65 times more likely 
to appropriately control of blood glucose.
Nutritional and anthropometric outcomes
Two studies reporting nutritional and anthropometric 
outcomes (one in South Africa and the Philippines, 
respectively) revealed improved health outcomes with 
user charges removal for maternal health services 
and tertiary care33 44 (online supplementary table 6). 
Outcomes measured included weight:height ratio. 
Tanaka et al, a high-quality study, examined the removal 
of user charges for newborns and children in South Africa 
and found a significant increase in average weight-for-age 
Z-score for newborns, and weight-for-height Z-score for 
children, with increased access to health services as the 
important determinant of nutritional improvement.
differential impact of user charges and explanatory factors 
for improvement in health outcomes
The relationship between reduced user charges and 
improved health outcomes was more evident in studies 
focusing on children and lower-income populations. Six 
out of seven studies26 30 32 33 41 44 focusing on children and 
infants found improved health following a reduction in 
user charges, including two studies on improved general 
health, two on reduced neonatal mortality, one on infec-
tious disease–related outcomes and one on nutritional 
outcomes.
Among the nine studies24 25 27 29 33 40 42–44 evaluating 
the impact of reducing user charges for the poor 
(including eight studies on economically poor and one 
on people working in informal sectors), seven studies 
(78%) found improved health outcomes following user 
charges removal. In comparison, of the other eight 
studies23 26 28 30–32 39 41 focusing on the impact of user 
charge policy for the general population, five (63%) 
found improved health outcomes following user charge 
removal. Two studies assessed and compared the differ-
ential effect of user charges by population groups, with 
mixed findings. One analysis found that the magnitude of 
reduction in neonatal mortality was larger among women 
from the lower castes or indigenous ethnic groups,32 
while the other study found similar policy effect among 
various income groups.28
Among the 14 studies reporting healthcare use, 12 
found access to and use of healthcare increased following 
reduction in user charges, and nine further found the 
increase in healthcare use along with improved health 
outcomes. Increased access to healthcare due to reduced 
user charges of care was posited as the possible explana-
tory factor for better health outcomes in five quasi-exper-
imental studies.29 32 40 41 44 For example, Lamichhane et 
al, a high-quality study, evaluated the impact of free birth 
delivery programme on neonatal mortality in Nepal,32 
and found a 4%–6.9% reduction in neonatal death in 
the treatment group compared with control group. The 
reduced neonatal mortality was consistent with a 6.1%–
8.2% increase in women delivering with assistance from 
skilled birth assistants and an increased use of public 
facilities, which are possible factors to explain the associa-
tion between reduced user charges and reduced neonatal 
mortality.
dIsCussIon
Main indings and interpretation
Our study is the first to examine and synthesise RCT and 
QE evidence on the relationship between user charges 
and population health outcomes in LMICs. Our findings 
are broadly consistent with evidence from HICs which 
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Table 3 Summary of the impact of user charges on certain health outcomes and secondary outcomes
Study Intervention Population
Improved 
general 
health
Improved 
mortality 
outcomes
Improved 
infectious 
disease–
related 
outcomes
Improved 
chronic 
disease–
related 
outcomes
Improved 
nutritional 
outcomes
Increased 
access to 
primary 
care or 
outpatient
Increased 
access to 
secondary 
care
Increased 
access to 
tertiary 
care or 
inpatient
Improved 
financial 
protection Notes
Study 
quality
Decreased user charges
  Nguyen and 
Wang26
Before: user fees in the 
public hospitals were a major 
inancial burden
After: free care including 
inpatient and outpatient 
services, and associated 
laboratory tests and generic 
medicines
Vietnam—non-
poor children 
under 6 years old
↑ – – – – – ↑ ↓ ↑ There was a 
‘substitution’ effect 
between increased use 
of secondary hospitals 
and decreased use of 
tertiary hospitals
High
  Sood and 
Wagner24
Before: unspeciied
After: no premiums or 
copayments at the point of 
tertiary care at both private 
and public hospitals in 
2010–2012
India—
poor population
↑ – ↑ – – – – ↑ – There was a 
‘substitution’ effect 
between increased 
use of tertiary care and 
readmission
Moderate
  Beuermann23 Before: pay out-of-pocket 
fees (amount unspeciied)
After: no user fee for 
healthcare services (ie, 
doctor’s consultation, 
diagnosis, surgeries)
Jamaica—
general population
↑ – – – – – – – – Improved general health 
had a positive labour 
supply effect with 
increased labour hours
Moderate
  Bauhoff et al27 Before: unspeciied
After: comprehensive beneit 
package with few coverage 
limits and no copayments for 
beneiciaries; basic universal 
package subjected to 
copayments of 25%–50% for 
non-MIP population
Georgia—
poor population
→ – – – – → – → ↑ The reduction of user 
charges provided 
inancial protection, but 
little impact on service 
use and self-reported 
health status
Moderate
  Guindon25 Before: unspeciied
After: no deductibles for 
most outpatient and inpatient 
care at government facilities 
and drugs on the Ministry 
of Health list, inanced 
from general government 
revenues at both national 
(75%) and provincial (25%) 
levels
Vietnam—
poor population
→ – – – – → – ↑ – Low
  Aggarwal29 Before: full cost for treatment
After: free outpatient 
diagnosis for all types of 
medical events and up 
to 50% discount on all 
laboratory tests
India—
disadvantaged 
rural general 
population
↑ – – – – ↑ – ↑ ↑ The author suggested 
that decreased user 
charges increased 
access to healthcare 
services and improved 
inancial protection, 
which should translate 
into better health 
outcomes
Moderate
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  Yiqiu Wang 
et al28
Before: unspeciied
After: out-of-pocket reduced 
26%–35% (covered service 
not speciied)
China—
rural general 
population (age 12 
year and above)
→ – – – – ↓ ↑ – → Low
  Nguyen and 
Lo Sasso30
Before: unspeciied
After: free care at public 
facilities for inpatient 
and outpatient services 
(excluding non-prescription 
medicines)
Vietnam—
children under age 
of 6
↑ – – – – ↑ – ↑ → Moderate
  Sood et al40 Before: unspeciied
After: free tertiary care at 
the point of service in both 
private and public hospitals
India—
poor population
– ↑ – – – – – ↑ ↑ Both increased access 
to healthcare and 
reduced out-of-pocket 
expenditure might have 
contributed to reduction 
in mortality
Moderate
  Ansah et al39 Before: unspeciied
After: free primary care, 
drugs and initial secondary 
care on moderate anaemia
Ghana—
rural children age 
under 5
– → → → – ↑ – – – Increased primary care 
use did not improve 
health. A possible 
reason could be that 
user fees may not be the 
major inancial barrier 
to care
High
  McKinnon et 
al41
Before: unspeciied
After: free deliveries in 
public, private and facility-
based health facilities, 
covering all normal 
deliveries, management 
of assisted deliveries 
including caesareans, and 
management of medical and 
surgical complications of 
delivery (Ghana)
Free deliveries in all public 
dispensaries and health 
centres, including all supplies 
required for delivery. The 
policy did not initially cover 
delivery fees in district 
hospitals and thus did not 
apply to caesarean sections 
(Kenya)
Covers normal deliveries 
at health posts and health 
centres and caesarean 
sections at district and 
regional hospitals (Senegal)
Multi-African 
countries—
women
– ↑ – – – – ↑ – – Removing user fees 
increased facility-
based deliveries and 
contributed to reduction 
in neonatal mortality
Moderate
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  Lamichhane 
et al32
Before: unspeciied
After: free delivery at public 
facilities
Nepal—women 
(15–49 years old)
– ↑ – – – – ↑ – – Reduction in mortality 
was consistent with 
the increased use of 
skilled birth assistance 
and public facilities for 
delivery
High
  Quimbo et al Before: 49% of total health 
expenditure paid out-of-
pocket
After: increase peso ceilings 
to eliminate copayment for 
hospitalisation
Philippines—
poor children
– – ↑ – ↑ – – – – Low
  Rivera-
Henandez 
et al
Before: unspeciied
After: remove copayment for 
crucial healthcare services 
for diagnosis and treatment 
of diabetes and hypertension
Mexico—poor 
population aged 
50 and above
– – – ↑/→ – ↑ – – – Moderate
  Sosa-Rubi 
et al42
Before: unspeciied
After: no copayment for 
speciic type of healthcare 
received
Mexico—
poor population 
(aged 20–80 years)
– – – ↑ – ↑ ↑ – – Decreased user charges 
increased access to 
healthcare and improve 
blood glucose level 
control
Moderate
  Tanaka44 Before: unspeciied
After: free services to 
pregnant women included 
prenatal and postnatal 
care from conirmation of 
pregnancy until 42 days 
after delivery, and all health 
services to children under 6 
years old became free
South Africa—
poor women and 
children under 6 
years old
– – – – ↑ – – – – Improved child health 
status was through 
increased access to 
health services
High
Increased user charges
  Huang and 
Gan31
Before: Outpatient care: 
around 30%–40% of total 
health expenditure were paid 
out-of-pocket.
Inpatient care: around 20% 
of total health expenditure 
were paid out-of-pocket
After:
Outpatient care: around 86% 
of total expenditure were 
paid out-of-pocket
Inpatient care: around 28% 
of total health expenditure 
were paid out-of-pocket
China—
urban general 
employees
→ – – – – ↓ – → – Increased user charges 
decreased outpatient 
use and expenditure but 
not for inpatient use and 
expenditure, and health 
outcomes
Low
→, not statistically signiicant change; ↓, negative change; ↑, beneicial effect on health or increased use/expenditure.
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show that user charges may have adverse impacts on 
health outcomes.11 34–36 45 A systematic review by Goldman 
et al
36 found that increased cost sharing for prescription 
drugs was associated with reduced drug treatment and 
adherence, in particular for chronically ill patients, 
resulting in more use of expensive medical services 
such as hospitalisation and emergency visits. This study 
also suggested that such an adverse effect was likely to 
be magnified among the poor, who are more price sensi-
tive. However, our study findings contrast with a recent 
systematic review which focused on maternal health 
outcomes in LMICs. Dzakpasu et al synthesised evidence 
and found that reduced user charges were associated 
with increased facility deliveries, yet with little effect on 
maternal health outcomes.37 The inconsistency between 
our study findings on health outcomes is likely due to 
the broader inclusion criteria by Dzakpasu et al, which 
included weaker study designs (mainly cross-sectional 
studies) that are potentially subject to bias. In contrast, 
our review only included evidence from studies adopting 
RCT or QE study designs that would reduce bias arising 
from potential confounders, therefore strengthening 
causal inference.37
Our review includes several important caveats. First, 
most studies included here were conducted in middle-in-
come countries, specifically in China, India and Mexico. 
There were only two studies conducted in low-income 
countries (Nepal and Senegal). Therefore, it is unclear 
as to whether the results could be extended in other 
LMICs at different levels of economic and health system 
development. Second, a majority of the studies included 
have a follow-up period of health outcomes of less 
than 5 years. Future studies should examine the long-
term health effects of changes in user charge policies. 
Although user charges were introduced to raise funding 
for health systems in several LMICs in 1980s, our review 
only included one study that evaluated the impact of 
increased user charges on health outcomes. These may 
reflect the fact that fewer studies adopted QE study 
designs until more recently or many user charge policies 
were not properly evaluated at the time.
Furthermore, the type of evidence contained in 
RCTs and QEs is unable to support clarity on a range 
of important questions about the mechanisms by which 
user fees and health outcomes are inversely related. 
Likely mechanisms include improved access to effective 
healthcare and reduced impoverishment from health-
care payments with their associated health effects. But 
health markets are complex, and the price of accessing 
public services is only one of a set of key variables in those 
markets. Implications for the mix of public and private, 
effective and ineffective and higher and lower priced 
healthcare options sought, the timeliness of health-
care-seeking decisions and quality of care across all the 
providers in the market among many other variables 
are contingent on a host of other contextually specific 
factors such as the pre-existing public–private mix in 
any health system, the economic capacity of populations 
affected, the price levels of other providers and other 
goods and services, and the regulatory and governance 
environments. Some measurements of health may not 
be possible to discern whether user charges had limited 
effects on health outcomes, or that the conditions 
measured or the populations studied were not sensitive 
to the changes.38 Future studies should also use compre-
hensive measures for patients’ health such as patients’ 
use of secondary care, clinical and self-reported health 
outcomes, and mortality rates. Despite the complexity of 
the mechanisms of effect and the contextual variability of 
the factors involved, RCTs and QEs suggest quite clearly 
that user charges are a population health–damaging 
policy. Few health system policy assessments can produce 
such a clear result.
Policy and research implications
An important finding of our review is that decreased 
user charges lead to improvements in health outcomes, 
especially for children and low-income groups. A poten-
tial reason behind this association is that reducing user 
charges increases access to healthcare. These findings 
highlight the importance of moving away from user 
charges to finance UHC, and towards contributory 
schemes based on prepayment through taxation and 
insurance contributions with large-scale risk pools that 
enable cross-subsidisation from the healthy and wealthy 
to the sick and low-income groups.4
This evidences the importance of public finance for 
subsidising the costs of healthcare for low-income and 
disadvantaged populations, and as an effective policy 
lever to reduce inequities in access and improve health 
outcomes.4 46 47 While all stand to benefit from enhanced 
financial protection brought about by greater reliance on 
prepayment and cross-subsidisation, the lowest-income 
and less healthy populations will benefit most, as these 
groups are more likely to face financial hardship due to 
ill health. Replacing user charges with public funding for 
these disadvantaged populations should help to reduce 
financial barriers to accessing care, in turn, improving 
health outcomes for these groups and promoting equity 
in health.46 48
ConClusIon
In summary, the published evidence to date suggests 
that reducing user charges is likely to have beneficial 
effects on health outcomes and reduce health inequali-
ties in LMICs. Our study supports the elimination of user 
charges for low-income groups and children, and WHO’s 
call for accelerating progress towards UHC in LMICs.
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